Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zoledronate for prevention of steroid-associated bone loss during multiple sclerosis relapse
2008-005304-93Phase 4Terminated
- Sponsor
- North Bristol NHS Trust
- Start
- Dec 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of zoledronic acid in osteoporosis and multiple sclerosis (MS) (2 arms), sponsored by North Bristol NHS Trust. Primary endpoint: Serum CTX at day 7. Started Dec 2008; status: terminated.
02
Drugs
zoledronic acid
03
Conditions
osteoporosismultiple sclerosis (MS)
Beyond the preview
Go deeper on 2008-005304-93.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-005304-93.